Assessing disruptions in adherence to antidepressant treatments after breast cancer diagnosis

Chou Yi-Ting; Winn Aaron N.; Rosenstein Donald L.; Dusetzina Stacie B.

首页> 外文期刊>Pharmacoepidemiology and drug safety >Assessing disruptions in adherence to antidepressant treatments after breast cancer diagnosis

【24h】

Assessing disruptions in adherence to antidepressant treatments after breast cancer diagnosis

机译：评估乳腺癌诊断后抗抑郁治疗粘附的中断

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposeLong-term treatment with antidepressants can lessen the symptoms of depression, but health-related crisessuch as a cancer diagnosismay disrupt ongoing depression care. The study aims to estimate the effect of receiving a breast cancer diagnosis on antidepressant adherence among women with depression.

机译：用抗抑郁药的Purposelong-术语治疗可以减少抑郁症的症状，但与癌症诊断扰乱持续抑郁护理的患者有关的睾丸相关。该研究旨在估算接受乳腺癌诊断对抑郁症患者抗抑郁症依赖的影响。

著录项

来源
《Pharmacoepidemiology and drug safety》 |2017年第6期|共9页
作者
Chou Yi-Ting; Winn Aaron N.; Rosenstein Donald L.; Dusetzina Stacie B.;
展开▼
作者单位

Univ North Carolina Chapel Hill UNC Eshelman Sch Pharm Div Pharmaceut Outcomes &

Policy Chapel;

Univ North Carolina Chapel Hill UNC Gillings Sch Global Publ Hlth Dept Hlth Policy &

Management;

Univ North Carolina Chapel Hill UNC Sch Med Dept Psychiat Chapel Hill NC USA;

Univ North Carolina Chapel Hill UNC Eshelman Sch Pharm Div Pharmaceut Outcomes &

Policy Chapel;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词
adherence; breast cancer; antidepressants; psycho-oncology; supportive care; SEER-Medicare; pharmacoepidemiology;

机译：依恋;乳腺癌;抗抑郁药;心理肿瘤;支持性护理;Seer-Medicare;药物病变学;

相似文献

外文文献
中文文献
专利

1. Assessing disruptions in adherence to antidepressant treatments after breast cancer diagnosis [J] . Chou Yi-Ting, Winn Aaron N., Rosenstein Donald L., Pharmacoepidemiology and drug safety . 2017,第6期

机译：评估乳腺癌诊断后抗抑郁治疗粘附的中断
2. TBCRC049: A phase II non-randomized study to assess the safety and efficacy of the combination of tucatinib and trastuzumab and capecitabine for treatment of leptomeningeal metastases in HER2 positive breast cancer TBCRC049: A phase II non-randomized study to assess the safety and efficacy of the combination of tucatinib and trastuzumab and capecitabine for treatment of leptomeningeal metastases in HER2 positive breast cancer [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：TBCRC049：II期非随机性研究，以评估Tucatinib和Trastuzumab和Capecitabine的组合的安全性和功效，用于治疗Her2阳性乳腺癌TBCRC049中的百分声膜转移：II期非随机性研究，以评估安全性和疗效 Tucatinib和Trastuzumab和Capecitabine的组合治疗HER2阳性乳腺癌中的百分症转移
3. Adherence to treatment guidelines and survival in patients with early-stage breast cancer by age at diagnosis [J] . VanDeWaterW., BastiaannetE., DekkersO.M., The British Journal of Surgery . 2012,第6期

机译：依诊断年龄坚持早期乳腺癌患者的治疗指南和生存
4. Conceptual Schema of Breast Cancer: The background to design an efficient information system to manage data from diagnosis and treatment of breast cancer patients [C] . Burriel Veronica, Pastor Oscar IEEE-EMBS International Conference on Biomedical and Health Informatics . 2014

机译：乳腺癌概念图式：设计高效信息系统以管理乳腺癌患者诊断和治疗数据的背景
5. The effect of depression and antidepressants on cost, survival and adherence to hormone therapy in breast cancer. [D] . Noxon, Virginia. 2016

机译：抑郁症和抗抑郁药对乳腺癌的治疗费用，生存率和激素治疗依从性的影响。
6. Assessing Disruptions in Adherence to Antidepressant Treatments after Breast Cancer Diagnosis [O] . Yi-Ting Chou, Aaron N. Winn, Donald L. Rosenstein, -1

机译：评估乳腺癌诊断后坚持抗抑郁治疗的依从性
7. Assessing disruptions in adherence to antidepressant treatments after breast cancer diagnosis [O] . Yi-Ting Chou, Aaron N. Winn, Donald L. Rosenstein, 2017

机译：评估乳腺癌诊断后抗抑郁药物粘附的中断

Assessing disruptions in adherence to antidepressant treatments after breast cancer diagnosis

摘要

著录项

相似文献

相关主题

期刊订阅